 |
 |
 |
|||||||||
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
||
 |
|
|
|
|
|
|
|
|
|
|
|
Agenda
 |
Thursday, October 21, 2010 |
||
| 7:55 am | Welcome and Announcements | |
| Session I: | Contemporary Issues in Heart Failure Management Moderators: Randall C. Starling, MD, MPH and Nicholas G. Smedira, MD |
|
| 8:00 am | Quality and Outcomes Data in Heart Failure - Clyde W. Yancy, MD | |
| 8:20 am | Expanding Indications for CRT: Putting MADIT-CRT into the Context of Heart Failure Practice - Bruce D. Lindsay, MD | |
| 8:40 am | Risk Stratification in Heart Failure Using Novel Imaging Techniques - Thomas Marwick, MD, PhD | |
| 9:00 am | The Evolution of MCS over the Past 30 Years - O. Howard Frazier, MD | |
| 9:20 am | Are We Ready for LVADS in Class III Patients? - Joseph G. Rogers, MD | |
| 9:40 - 10:00 am | Panel Discussion | |
| 10:00 - 10:30 am | Break | |
| Session II: | Contemporary Issues in Heart Failure Management Moderators: Christine S. Moravec, PhD and Robert Hobbs, MD |
|
| 10:30 am | Registries and Guidelines: Have They Helped Us Provide Better Patient Care in the Real World? - Eiran Gorodeski, MD, MPH | |
| 10:50 am | Addressing Anemia in Heart Failure: What Have We Learned? - W. H. Wilson Tang, MD | |
| 11:10 am | New Insights into the Cardiorenal Syndrome - Maria Rosa Costanzo, MD | |
| 11:30 am | Vasodilators in the Setting of ADHF - John R. Teerlink, MD | |
| 11:50 - 12:10 pm | Panel Discussion | |
| 12:10 - 1:15 pm | Lunch | |
| Session III: | Kaufman Center Award and Lecture Introduced by Randall C. Starling, MD, MPH |
|
| 1:15 pm | James B. Young, MD | |
| Session IV: | Clinical Trials of Drugs and Devices for Heart Failure Moderator: James B. Young, MD |
|
| 1:45 pm | Will Clinical Site Research Survive in the U.S. and Can We Afford It? - Robert M. Califf, MD | |
| 2:05 pm | The STICH Trial: What Went Wrong, What Went Right? - John V. Conte, MD | |
| 2:25 pm | Are the Patients We Study Those We Treat? - Clyde W. Yancy, MD | |
| 2:45 pm | The Economics of Developing New Drugs and Devices: Is the Pipeline for New Drugs “Drying Up”? - Steven Nissen, MD | |
| 3:05 pm | LVAD: Regulatory Issues Ileana - Ileana L. Piňa, MD, MPH | |
| 3:25 - 3:45 pm | Panel Discussion | |
| Session V: | Update on the Medical and Surgical Management of Ischemic Cardiomyopathy Moderator: Soon J. Park, MD |
|
| 3:45 pm | State of the Art Cardiac Regeneration with Stem Cells - Marc S. Penn, MD, PhD | |
| 4:05 pm | Ventricular Reconstruction: Indications, Physiologic Impact, Surgical Techniques, and Outcomes - Robert A.E. Dion, MD | |
| 4:25 pm | The Treatment of Ischemic Mitral Valve Disease: Imaging - Robert A. Levine, MD Repair - Tomislav Mihaljevic, MD |
|
| 5:00 pm | Panel Discussion | |
| 5:30 pm | Poster Presentations / Attendee Reception / Exhibits | |
 |
||
Friday, October 22, 2010 |
||
| Session VI: | Mechanical Circulatory Support and Transplant: Patient Selection Moderators: David O. Taylor, MD and Nicholas G. Smedira, MD |
|
| 8:00 am | Where is the Data That Obesity is a Contraindication to Heart Transplant and MCS? - David O. Taylor, MD | |
| 8:20 am | Gastric Bypass Surgery for Heart Failure: The Impact of Weight Loss on CV Structure and Function - Philip R. Schauer, MD | |
| 8:40 am | Strategies for LVAD Therapy: Does BTT, BTC and DT Impact Management and Outcomes? - Benjamin C. Sun, MD | |
| 9:00 am | Pre-Operative Predictors of Post LVAD Mortality - Leslie W. Miller, MD | |
| 9:20 am | A Good LVAD is Better Than a Bad Transplant! - George M. Wieselthaler, MD | |
| 9:40 - 10:00 am | Panel Discussion | |
| 10:00 - 10:20 am | Break | |
| Session VII: | Management of the Patient on MCS in the Continuum of Care Moderator: Nicholas G. Smedira, MD and George M. Wieselthaler, MD |
|
| 10:20 am | Management of Acute Decompensated Heart Failure and Shock (Point/Counterpoint) Back to the Future: ECMO Should be the First Choice - Pascal N. Leprince MD, PhD Avoid an Oxygenator At All Costs: Tandem Heart or Impella - Edward Soltesz, MD |
|
| 10:50 am | Managing RV Failure (Point/Counterpoint) Temporary RV Support is the Best Strategy - Leslie W. Miller, MD Early Planned BiV Support Results in Improved Outcomes - Michael A. Acker, MD |
|
| 11:20 am | Eliminate Drive-Line Infection - Nicholas G. Smedira, MD | |
| 11:35 am | Neurological Events: Patient? Device? Management? - Maria Mountis, DO | |
| 11:50 am | Are ICDs Beneficial in the LVAD Population - Daniel J. Cantillon, MD | |
| 12:05 pm | Outpatient Management of the “Destination” Patient: Are Focused Clinics and Telemanagement the Answer? - Robert L. Kormos, MD | |
| 12:20 pm | Utilizing Best Practices to Reduce Readmissions in the LVAD Population - Laura D. Damme, RN, MPH | |
| 12:35 - 12:55 pm | Panel Discussion | |
| 12:45 pm | Lunch | |
| Session VIII: | The Present and Future of Innovation in MCS Moderator: Robert L. Kormos, MD |
|
| 2:00 pm | Total Artificial Heart Why I Love It - Jack G. Copeland, MD Why I Hate It - Gonzalo Gonzalez-Stawinski, MD |
|
| 2:40 pm | Update on New Technology: Duraheart, Terumo, and Heartware - Aly El-Banayosy, MD | |
| 3:00 pm | Update on New Technology: Tandem Heart, Impella, Circulite - William E. Cohn, MD | |
| 3:20 pm | Maximizing Reimbursement for Innovation - Robin Roberts Bostic | |
| 3:40 pm | Will MCS Replace Heart Transplant in this Decade? - Leonard Golding, MD | |
| 4:00 - 4:20 pm | Panel Discussion | |
| Adjourn | ||
 |
||
